| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,283 |
24,876 |
$1.88M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,553 |
25,982 |
$1.80M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12,405 |
10,276 |
$410K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,098 |
7,819 |
$239K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,836 |
5,655 |
$127K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,728 |
2,385 |
$70K |
| 99051 |
|
7,874 |
7,139 |
$68K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,661 |
9,021 |
$66K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,385 |
3,783 |
$66K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,277 |
1,272 |
$39K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
509 |
333 |
$18K |
| 93000 |
|
1,254 |
1,162 |
$17K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
565 |
565 |
$15K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
199 |
199 |
$14K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
155 |
153 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
10,712 |
10,005 |
$11K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,415 |
2,820 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
452 |
380 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,062 |
2,884 |
$7K |
| 81002 |
|
4,327 |
3,911 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
102 |
102 |
$5K |
| 86769 |
|
194 |
194 |
$4K |
| 82947 |
|
1,817 |
1,346 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
301 |
298 |
$3K |
| 90674 |
|
145 |
145 |
$3K |
| 0011A |
|
78 |
78 |
$3K |
| 0031A |
|
80 |
80 |
$2K |
| 0001A |
|
58 |
57 |
$2K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
13 |
13 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,053 |
771 |
$2K |
| 87807 |
|
487 |
329 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,527 |
1,113 |
$2K |
| 69210 |
|
61 |
53 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
618 |
514 |
$529.50 |
| J1940 |
Injection, furosemide, up to 20 mg |
729 |
647 |
$304.30 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
110 |
81 |
$170.91 |
| 99348 |
|
30 |
12 |
$69.96 |
| 87070 |
|
16 |
16 |
$40.16 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
55 |
25 |
$32.94 |
| 91300 |
|
20 |
17 |
$3.25 |